Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Parkinson's Disease

  Free Subscription


16.09.2019

2 Brain Res
1 Exp Neurol
2 Int J Neurosci
2 J Neural Transm (Vienna)
1 J Neurochem
3 Lancet Neurol
3 Mov Disord
1 Neurobiol Dis
2 Neurol Genet
2 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain Res

  1. CAVELLI M, Prunell G, Costa G, Velasquez N, et al
    Electrocortical high frequency activity and respiratory entrainment in 6-hydroxydopamine model of Parkinson's disease.
    Brain Res. 2019 Sep 6:146439. doi: 10.1016/j.brainres.2019.146439.
    PubMed     Text format     Abstract available

  2. NADEAU J, Smith T, Lamontagne-Proulx J, Bourque M, et al
    Neuroprotection and immunomodulation in the gut of parkinsonian mice with a plasmalogen precursor.
    Brain Res. 2019 Sep 13:146460. doi: 10.1016/j.brainres.2019.146460.
    PubMed     Text format     Abstract available


    Exp Neurol

  3. ZHANG J, Lv S, Tang G, Bian G, et al
    Activation of calcium-impermeable GluR2-containing AMPA receptors in the lateral habenula produces antidepressant-like effects in a rodent model of Parkinson's disease.
    Exp Neurol. 2019;322:113058.
    PubMed     Text format     Abstract available


    Int J Neurosci

  4. KATAOKA H, Sugie K
    Risk for later Rapid Eye Movement sleep behavior disorder in Parkinson's disease: A 6-year prospective study.
    Int J Neurosci. 2019 Sep 13:1-11. doi: 10.1080/00207454.2019.1667796.
    PubMed     Text format     Abstract available

  5. YANG Y, Qian J, Mei J, Zhong K, et al
    In vivo detection of metabolic changes in the striatum of proteasomal inhibition-induced Parkinson's disease in rats using proton MR spectroscopy at 9.4 T.
    Int J Neurosci. 2019 Sep 13:1-12. doi: 10.1080/00207454.2019.1667783.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  6. ROOS DS, Twisk JWR, Raijmakers PGHM, Doty RL, et al
    Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease.
    J Neural Transm (Vienna). 2019 Sep 12. pii: 10.1007/s00702-019-02074.
    PubMed     Text format     Abstract available

  7. MOSSNER JM, Patil PG, Chou KL
    Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
    J Neural Transm (Vienna). 2019 Sep 7. pii: 10.1007/s00702-019-02076.
    PubMed     Text format     Abstract available


    J Neurochem

  8. LI T, Zhang W, Kang X, Yang R, et al
    Salidroside Protects Dopaminergic Neurons by Regulating the Mitochondrial MEF2D-ND6 Pathway in the MPTP/MPP(+) -Induced Model of Parkinson's Disease.
    J Neurochem. 2019 Sep 14. doi: 10.1111/jnc.14868.
    PubMed     Text format     Abstract available


    Lancet Neurol

  9. BLAUWENDRAAT C, Nalls MA, Singleton AB
    The genetic architecture of Parkinson's disease.
    Lancet Neurol. 2019 Sep 11. pii: S1474-4422(19)30287.
    PubMed     Text format     Abstract available

  10. VAN DER KOLK NM, de Vries NM, Kessels RPC, Joosten H, et al
    Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial.
    Lancet Neurol. 2019 Sep 11. pii: S1474-4422(19)30285.
    PubMed     Text format     Abstract available

  11. ELLIS T
    Exercise in Parkinson's disease: are we narrowing in on the essential elements?
    Lancet Neurol. 2019 Sep 11. pii: S1474-4422(19)30348.
    PubMed     Text format    


    Mov Disord

  12. SU TH, Yang HC, Tseng TC, Chou SW, et al
    Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism.
    Mov Disord. 2019 Sep 10. doi: 10.1002/mds.27848.
    PubMed     Text format     Abstract available

  13. IWAKI H, Blauwendraat C, Leonard HL, Kim JJ, et al
    Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.
    Mov Disord. 2019 Sep 10. doi: 10.1002/mds.27845.
    PubMed     Text format     Abstract available

  14. LEE PC, Artaud F, Cormier-Dequaire F, Rascol O, et al
    Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.
    Mov Disord. 2019 Sep 13. doi: 10.1002/mds.27854.
    PubMed     Text format     Abstract available


    Neurobiol Dis

  15. CHEN CC, Yeh CH, Chan HL, Chang YJ, et al
    Subthalamic nucleus oscillations correlate with vulnerability to freezing of gait in patients with Parkinson's disease.
    Neurobiol Dis. 2019 Sep 5:104605. doi: 10.1016/j.nbd.2019.104605.
    PubMed     Text format     Abstract available


    Neurol Genet


  16. Erratum: Genome-wide Brain DNA methylation analysis suggests epigenetic reprogramming in Parkinson disease.
    Neurol Genet. 2019;5:e355.
    PubMed     Text format     Abstract available


  17. Erratum: Genetic risk of Parkinson disease and progression: An analysis of 13 longitudinal cohorts.
    Neurol Genet. 2019;5:e354.
    PubMed     Text format     Abstract available


    Rev Neurol (Paris)

  18. TORUN NA, Senel GB, Gunduz A, Karadeniz D, et al
    Sleep parameters associated with long-term outcome following subthalamic deep brain stimulation in Parkinson's disease.
    Rev Neurol (Paris). 2019 Sep 11. pii: S0035-3787(19)30473.
    PubMed     Text format     Abstract available

  19. CAPARROS LEFEBVRE D
    Food toxins and the Caribbean Parkinson plus types.
    Rev Neurol (Paris). 2019 Sep 10. pii: S0035-3787(19)30616.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: